PDSB · CIK 0001472091 · FY2025 live · 2025-12-31
PDS Biotechnology Corp
View as
Model
Classic Z
FY2025
−12.36
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−12.36
Z″ −25.61
Score −12.36 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.621.2 × = 0.74X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−7.101.4 × = −9.94X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−1.033.3 × = −3.41X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
0.440.6 × = 0.26X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
PDS Biotechnology Corp is on classic Z at −12.36 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 12th percentile in Healthcare.
- BOLTDistressBolt Biotherapeutics, Inc.−12.34
- ATNMDistressActinium Pharmaceuticals, Inc.−12.32
- MODDDistressModular Medical, Inc.−12.19
- MREODistressMereo BioPharma Group plc−12.17
- RCELDistressAVITA Medical, Inc.−12.07
- IXHLDistressIncannex Healthcare Inc.−12.73
- CUEDistressCue Biopharma, Inc.−11.97
- HOWLDistressWerewolf Therapeutics, Inc.−11.75
KPI widgets
Current assets
$28M
Total assets
$30M
Current liabilities
$9M
Total liabilities
$21M
Working capital
$19M
Retained earnings
−$217M
EBIT
−$32M
Total sales
$0
Book equity
$9M
Accession 0001140361-26-012030. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 12 Sept 2026.